Navigation Links
MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
Date:10/31/2007

riety of treatments available in the United States, asthma is still poorly controlled and many patients require daily maintenance treatment with combination therapy.

Chronic obstructive pulmonary disease refers to several diseases, including chronic bronchitis and emphysema, which cause airflow obstruction and interfere with normal breathing. According to the National Heart Lung and Blood Institute, more than 12 million people in the United States have been diagnosed with COPD and another 12 million likely have the illness but do not know it. COPD is one of the leading causes of death and disability in the United States and is caused in many cases by heavy cigarette smoking in earlier life.

According to Datamonitor, a leading market research company, the potential market for asthma and COPD was estimated at approximately $16 billion in 2005, with expected growth to approximately $30 billion by 2015.

About MAP Pharmaceuticals, Inc.

MAP Pharmaceuticals, Inc. uses proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. The Company has several proprietary product candidates in clinical development that address large market opportunities, including its two most advanced product candidates, a proprietary formulation of nebulized budesonide for the potential treatment of children with asthma, and a proprietary formulation of inhaled dihydroergotamine for the potential treatment of migraine, as well as a proprietary combination of an inhaled corticosteroid and a long-acting beta2-agonist for the potential treatment of asthma and chronic obstructive pulmonary disease. Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

Forward-Looking Statements

In addition to statements of historical fact
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... ... August 01, 2015 , ... BeverlyD, owner and founder ... foundation, making hers the very first small business donation to kick off the campaign ... over thirty years. Her legacy includes a complete line of raw, organic hair care ...
(Date:7/31/2015)... ... July 31, 2015 , ... That’s right, the STASH awards ... awards? The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, featured in ... products that have stood the test of time. These include lighting products, organic ...
(Date:7/31/2015)... ... 01, 2015 , ... The Honor Society of Nursing, Sigma Theta Tau International ... Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto Rico. Key nurse leaders from ... Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, Unit of Human Resources for ...
(Date:7/31/2015)... ... , ... Precision Aesthetics is New York’s only Thermage skin tightening pinnacle and ... of Exilis non-surgical fat reduction in New York. Due to its unparalleled level ... clientele. Many patients travel to New York to get their non-surgical skin tightening ...
(Date:7/31/2015)... ... July 31, 2015 , ... The 2nd annual Ride to Fight ... Memphis on October 3, 2015. The Ride to Fight On is a cycling fundraiser ... Methodist Healthcare, The West Clinic and The University of Tennessee Health Science Center. A ...
Breaking Medicine News(10 mins):Health News:March4thforWellBeing Foundation Kickoff 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3
... When pregnant women need medications, there is often ... drugs are clearly recognized to cause birth defects (thalidomide ... as safe, surprisingly little is known about most drugs, ... Informatics Program (CHIP) have created a preclinical model for ...
... By Alan Mozes HealthDay Reporter , TUESDAY, Jan. ... last month of pop star Miley Cyrus -- giggling and semi-coherent, ... inhaled. According to Cyrus, her addled state was the effect ... divinorum plant, including its active ingredient, a potent hallucinogen called ...
... In the first combat-zone study of its kind, a research ... a positive outlook in the most traumatic situations were less ... The study, which surveyed Army troops fighting in Iraq, ... regularly deal with traumatic events such as death. Training these ...
... body temperature of patients soon after they have suffered ... improve outcomes. The safety of therapeutic hypothermia for traumatic ... According to a Roundtable Discussion of renowned experts in ... depend on the clinical condition of individual patients. The ...
... Alliance for Chronic Diseases has announced its intention to ... on Hypertension in Low and Middle Income Countries A ... Catalan Institute of Oncology (ICO) has confirmed that the ... the reduction in consumption and passive exposure to smoke. ...
... medical imaging, including magnetic resonance imaging (MRI) and computed ... to radiologists, according to a study in the January ... of Radiology ( www.jacr.org ). "Radiologists ... diagnostic imaging (NDI) and are primarily responsible for its ...
Cached Medicine News:Health News:Model predicts a drug's likelihood of causing birth defects 2Health News:Pop Star's Use of Salvia Puts Hallucinogen in the Spotlight 2Health News:Pop Star's Use of Salvia Puts Hallucinogen in the Spotlight 3Health News:Pop Star's Use of Salvia Puts Hallucinogen in the Spotlight 4Health News:MSU leads first study of resiliency on the battlefield 2Health News:Optimizing patient outcomes after therapeutic hypothermia for traumatic brain injury 2Health News:Europe reins in the smoking habit 2
(Date:7/31/2015)... , July 31, 2015  Seeger Weiss LLP is reporting ... issued a warning letter to C.R. Bard, the manufacturer of ... adequate strides to correct violations the agency found at two ... violations after the FDA cited them during Inspectional Observations that ... Bard,s Tempe, AZ , location and on ...
(Date:7/31/2015)... 31, 2015 Today, the National Association ... ) issued a report urging greater accountability by ... taken against websites illegally selling medications online. As ... Identification Program Progress Report for State and Federal ... of websites illegally distribute medications and avoid retribution. ...
(Date:7/31/2015)... , July 31, 2015 The Physician-Patient ... release on July 28, 2015, "Surviving Your Hospital ... Fundraising for Patient Safety." A sentence ... should read: "PPAHS is a member ... on Opioids. For more information on the National Coalition ...
Breaking Medicine Technology:Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 3NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 3
... return to the use of,chimpanzees in AIDS research ... a paper released today in the journal,Alternatives to ... of,Chimpanzees in AIDS Vaccine Research" concludes that vaccine ... humans, and that claims of,chimpanzees, critical role and ...
... - Data Presented at ACG Annual Scientific ... Ironwood Pharmaceuticals,(formerly Microbia) today announced presentation ... delineating the role that cyclic guanosine,monophosphate (cGMP) ... that cGMP inhibits intestinal pain in a ...
Cached Medicine Technology:Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3
Clock oil, 6 grams net...
Knife sharpening back for Standard Knife, C Profile...
Knife sharpening kit...
... some sectioning work, it is necessary to cool ... Freezer can be fitted to most microtomes and ... or lower, depending on conditions. The equipment consists ... The cooling stage is best suited for operation ...
Medicine Products: